Abstract
Learning disability (LD) is a term frequently used to describe neurological disorders affecting academic and school performance. Although often applied, this term is not precisely defined. While the new DSM-V has substantially redefined LD, problems still remain, including the influence of different cultural experiences and the near absence of proposals for the application of biomarkers in LD diagnosis. This paper discusses these issues and calls for more emphasis to be placed on the identification and application of biomarkers for LD diagnosis. In addition, it proposes that these biomarkers should be incorporated into a more comprehensive bio-psycho-social diagnosis model of LD.